[Chronic hepatitis C: what to do if the first treatment failed?]

Gastroenterol Clin Biol. 2002 Apr:26 Spec No 2:B50-9.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Review

MeSH terms

  • Amantadine / administration & dosage
  • Amantadine / therapeutic use
  • Animals
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / prevention & control
  • Drug Therapy, Combination
  • Ethanol / adverse effects
  • Follow-Up Studies
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferons / administration & dosage
  • Interferons / adverse effects
  • Interferons / therapeutic use
  • Liver Cirrhosis / etiology
  • Liver Neoplasms / etiology
  • Liver Neoplasms / prevention & control
  • Mice
  • Mice, Transgenic
  • Multicenter Studies as Topic
  • Obesity / complications
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use
  • Risk Factors
  • Smoking / adverse effects
  • Time Factors

Substances

  • Antiviral Agents
  • Ethanol
  • Ribavirin
  • Interferons
  • Amantadine